News

January 31, 2013 — Cardiovascular Systems Inc. (CSI) announced CONFIRM study series data presented at the 2013 International Symposium on Endovascular Therapy (ISET).

The American College of Cardiology (ACC) has released the late-breaking clinical trials that will be highlighted as the cutting edge of cardiology at the ACC.13 annual meeting March 9-11 in San...

Spectranetics Peripheral Artery Disease Laser Atherectomy

The Spectranetics Corporation announced final results from the PATENT (Photo-Ablation using the TURBO-Booster(R) and Excimer Laser for In-Stent Restenosis Treatment) study evaluating the safety...

Bathing dangerous blood clots in special medication, breaking them up with jets of saline and vacuuming them out of the body is a fast, effective method of treating deep vein thrombosis (DVT),...

ProMRI Clinical Trial Biotronik EP Lab Pacemakers MRI

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved, with conditions, the ProMRI clinical trial via an Investigational Device Exemption. Biotronik is sponsoring the...

Boston Scientific Blazer Open-Irrgated Catheter Atrial Fibrillation ZERO AF

The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer open-irrigated temperature ablation Catheter...

CardioKinetics PARACHUTE IV Clinical Trial Heart Failure Treatments

CardioKinetix Inc. announced the enrollment of the first patients in PARACHUTE IV, the randomized pivotal U.S. trial of the minimally invasive Parachute Ventricular Partitioning Device for the...

January 16, 2013 — Americans' cardiovascular health varies greatly from state to state, according to new research in the Journal of the American Heart Association (JAHA). The study is the...

Biotronik BIOFLEX-I IDE Clinical Trial Puslar-18 Peripheral Artery Disease

Biotronik announced the first U.S. implant of their Pulsar-18 self expanding stent in the BIOFLEX-I IDE clinical trial. Carlos Mena of Yale University Medical Center performed the procedure.

Covidien DEFINITIVE LE Study Peripheral Artery Disease SilverHawk TurboHawk

Covidien announced the completion of enrollment in its DEFINITIVE AR (anti-restenosis) study. As the third study in the DEFINITIVE trial series, this randomized pilot is designed to address the...

Abbott Absorb bioresorbable stent

Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States. The randomized controlled trial will enroll about 2,250 patients and compare the performance of...

Biosensors International has announced enrollment of the first patient in LEADERS FREE, a clinical study involving BioFreedom, a polymer-free drug-coated stent (DCS) from Biosensors.

Biotronik Home Monitoring ECOST Clinical Trial ICDs

Biotronik announced that the European Heart Journal has published the clinical results of the ECOST trial (...

Miracor Medical Systems PICSO Clinical Trial Study

Miracor Medical Systems GmbH announced that its PICSO system was used for the first time under CE mark in the United Kingdom to treat a patient with a large acute heart attack, or ST-segment...

CathPCI Registry Interventional Cardiology Data Cath Lab JACC

A report from the CathPCI Registry, a data registry that includes information from 85 percent of the heart catheterization laboratories in the United States, is providing a vivid snapshot of the...

SCAI Ad Hoc PCI Stenting Cath Lab Clinical Trial

When tests reveal that a patient’s heart artery is blocked and blood flow to the heart is restricted, should the doctor fix it with a stent or stop the test and discuss treatment options with the...

The first patient has been implanted with the Boston Scientific Corporation next generation Ingevity pacing leads in a clinical trial designed to establish the safety, performance and...

Among deployed U.S. service members who died of combat or unintentional injuries between 2001-2011 and underwent autopsies, the prevalence of coronary atherosclerosis was 8.5 percent, with factors...

December 28, 2012 — Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to traditional antimalarial treatment decreases neuroinflammation and protects...

December 27, 2012 — Biotronik announced that the first implant has taken place in the BIOHELIX-I trial in the United States. The BIOHELIX–I trial is set to evaluate the safety and...